Monitoring Progression of Bioluminescent Tumors with PRISM™

PRISM In Vivo Imaging System

Monitoring progression of tumors with PRISM™ in vivo imaging system following IV injection of bioluminescent human neuroblastoma cell lines in NGS mice: N-91 tumors (top images) develop mainly in liver while IMR-32 tumors (bottom images) seed in bone marrow, liver and adrenal gland. Image courtesy of Sabine Herblot PhD from the Laboratory of Michel Duval M.D., CHU Saint Justine Research Center